Logo image of ABO.BR

ABO GROUP ENVIRONMENT (ABO.BR) Stock Fundamental Analysis

EBR:ABO - BE0974278104 - Common Stock

6.2 EUR
+0.05 (+0.81%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

4

Overall ABO gets a fundamental rating of 4 out of 10. We evaluated ABO against 42 industry peers in the Commercial Services & Supplies industry. Both the profitability and the financial health of ABO get a neutral evaluation. Nothing too spectacular is happening here. ABO is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

ABO had positive earnings in the past year.
ABO had a positive operating cash flow in the past year.
Each year in the past 5 years ABO has been profitable.
ABO had a positive operating cash flow in each of the past 5 years.
ABO.BR Yearly Net Income VS EBIT VS OCF VS FCFABO.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

1.2 Ratios

The Return On Assets of ABO (1.93%) is comparable to the rest of the industry.
ABO has a Return On Equity (7.34%) which is in line with its industry peers.
ABO has a Return On Invested Capital of 6.90%. This is in the better half of the industry: ABO outperforms 69.05% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ABO is in line with the industry average of 7.45%.
The last Return On Invested Capital (6.90%) for ABO is above the 3 year average (6.75%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.93%
ROE 7.34%
ROIC 6.9%
ROA(3y)2.67%
ROA(5y)2.95%
ROE(3y)9.24%
ROE(5y)10%
ROIC(3y)6.75%
ROIC(5y)6.66%
ABO.BR Yearly ROA, ROE, ROICABO.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

ABO has a Profit Margin (1.98%) which is in line with its industry peers.
In the last couple of years the Profit Margin of ABO has declined.
ABO's Operating Margin of 5.11% is fine compared to the rest of the industry. ABO outperforms 61.90% of its industry peers.
In the last couple of years the Operating Margin of ABO has declined.
ABO has a better Gross Margin (82.71%) than 83.33% of its industry peers.
In the last couple of years the Gross Margin of ABO has declined.
Industry RankSector Rank
OM 5.11%
PM (TTM) 1.98%
GM 82.71%
OM growth 3Y6%
OM growth 5Y-3.01%
PM growth 3Y-14.39%
PM growth 5Y-11.63%
GM growth 3Y-2.08%
GM growth 5Y-1.79%
ABO.BR Yearly Profit, Operating, Gross MarginsABO.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

4

2. Health

2.1 Basic Checks

ABO has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
ABO has about the same amout of shares outstanding than it did 1 year ago.
ABO has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, ABO has a worse debt to assets ratio.
ABO.BR Yearly Shares OutstandingABO.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ABO.BR Yearly Total Debt VS Total AssetsABO.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

ABO has an Altman-Z score of 2.06. This is not the best score and indicates that ABO is in the grey zone with still only limited risk for bankruptcy at the moment.
ABO's Altman-Z score of 2.06 is fine compared to the rest of the industry. ABO outperforms 66.67% of its industry peers.
ABO has a debt to FCF ratio of 12.48. This is a negative value and a sign of low solvency as ABO would need 12.48 years to pay back of all of its debts.
The Debt to FCF ratio of ABO (12.48) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.63 indicates that ABO is somewhat dependend on debt financing.
ABO has a Debt to Equity ratio (0.63) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 12.48
Altman-Z 2.06
ROIC/WACC1.12
WACC6.14%
ABO.BR Yearly LT Debt VS Equity VS FCFABO.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.3 Liquidity

ABO has a Current Ratio of 1.09. This is a normal value and indicates that ABO is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ABO (1.09) is worse than 64.29% of its industry peers.
ABO has a Quick Ratio of 1.06. This is a normal value and indicates that ABO is financially healthy and should not expect problems in meeting its short term obligations.
ABO's Quick ratio of 1.06 is in line compared to the rest of the industry. ABO outperforms 54.76% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.06
ABO.BR Yearly Current Assets VS Current LiabilitesABO.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

4

3. Growth

3.1 Past

The earnings per share for ABO have decreased strongly by -24.90% in the last year.
The Earnings Per Share has been growing slightly by 1.48% on average over the past years.
ABO shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.63%.
The Revenue has been growing by 14.83% on average over the past years. This is quite good.
EPS 1Y (TTM)-24.9%
EPS 3Y-1.79%
EPS 5Y1.48%
EPS Q2Q%-22.64%
Revenue 1Y (TTM)14.63%
Revenue growth 3Y14.71%
Revenue growth 5Y14.83%
Sales Q2Q%14.96%

3.2 Future

Based on estimates for the next years, ABO will show a decrease in Earnings Per Share. The EPS will decrease by -0.46% on average per year.
The Revenue is expected to grow by 14.99% on average over the next years. This is quite good.
EPS Next YN/A
EPS Next 2Y5.71%
EPS Next 3Y-0.46%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2Y23.53%
Revenue Next 3Y14.99%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ABO.BR Yearly Revenue VS EstimatesABO.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2026 2027 20M 40M 60M 80M 100M
ABO.BR Yearly EPS VS EstimatesABO.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2026 2027 0.1 0.2 0.3 0.4 0.5

2

4. Valuation

4.1 Price/Earnings Ratio

ABO is valuated quite expensively with a Price/Earnings ratio of 34.44.
The rest of the industry has a similar Price/Earnings ratio as ABO.
The average S&P500 Price/Earnings ratio is at 27.06. ABO is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 34.44
Fwd PE N/A
ABO.BR Price Earnings VS Forward Price EarningsABO.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

ABO's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ABO is cheaper than 64.29% of the companies in the same industry.
ABO's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 21.45
EV/EBITDA 7.13
ABO.BR Per share dataABO.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The decent profitability rating of ABO may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)23.3
EPS Next 2Y5.71%
EPS Next 3Y-0.46%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.53%, ABO has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 4.19, ABO has a dividend in line with its industry peers.
ABO's Dividend Yield is slightly below the S&P500 average, which is at 2.41.
Industry RankSector Rank
Dividend Yield 1.53%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y5.71%
EPS Next 3Y-0.46%
ABO.BR Yearly Income VS Free CF VS DividendABO.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

ABO GROUP ENVIRONMENT

EBR:ABO (9/5/2025, 7:00:00 PM)

6.2

+0.05 (+0.81%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.28%
Inst Owner ChangeN/A
Ins Owners85.24%
Ins Owner ChangeN/A
Market Cap65.53M
Analysts84
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.53%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 34.44
Fwd PE N/A
P/S 0.68
P/FCF 21.45
P/OCF 8.45
P/B 2.54
P/tB 4.34
EV/EBITDA 7.13
EPS(TTM)0.18
EY2.9%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.29
FCFY4.66%
OCF(TTM)0.73
OCFY11.83%
SpS9.07
BVpS2.44
TBVpS1.43
PEG (NY)N/A
PEG (5Y)23.3
Profitability
Industry RankSector Rank
ROA 1.93%
ROE 7.34%
ROCE 9.97%
ROIC 6.9%
ROICexc 9.5%
ROICexgc 13.6%
OM 5.11%
PM (TTM) 1.98%
GM 82.71%
FCFM 3.19%
ROA(3y)2.67%
ROA(5y)2.95%
ROE(3y)9.24%
ROE(5y)10%
ROIC(3y)6.75%
ROIC(5y)6.66%
ROICexc(3y)10.47%
ROICexc(5y)11.44%
ROICexgc(3y)13.66%
ROICexgc(5y)14.41%
ROCE(3y)9.75%
ROCE(5y)9.61%
ROICexcg growth 3Y3.29%
ROICexcg growth 5Y5.77%
ROICexc growth 3Y-2.3%
ROICexc growth 5Y0.98%
OM growth 3Y6%
OM growth 5Y-3.01%
PM growth 3Y-14.39%
PM growth 5Y-11.63%
GM growth 3Y-2.08%
GM growth 5Y-1.79%
F-Score6
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 12.48
Debt/EBITDA 1.29
Cap/Depr 60.56%
Cap/Sales 4.9%
Interest Coverage 3.48
Cash Conversion 61.27%
Profit Quality 161.04%
Current Ratio 1.09
Quick Ratio 1.06
Altman-Z 2.06
F-Score6
WACC6.14%
ROIC/WACC1.12
Cap/Depr(3y)61.35%
Cap/Depr(5y)64.84%
Cap/Sales(3y)4.92%
Cap/Sales(5y)5.25%
Profit Quality(3y)155.26%
Profit Quality(5y)177.18%
High Growth Momentum
Growth
EPS 1Y (TTM)-24.9%
EPS 3Y-1.79%
EPS 5Y1.48%
EPS Q2Q%-22.64%
EPS Next YN/A
EPS Next 2Y5.71%
EPS Next 3Y-0.46%
EPS Next 5YN/A
Revenue 1Y (TTM)14.63%
Revenue growth 3Y14.71%
Revenue growth 5Y14.83%
Sales Q2Q%14.96%
Revenue Next YearN/A
Revenue Next 2Y23.53%
Revenue Next 3Y14.99%
Revenue Next 5YN/A
EBIT growth 1Y4.44%
EBIT growth 3Y21.59%
EBIT growth 5Y11.37%
EBIT Next YearN/A
EBIT Next 3Y34.11%
EBIT Next 5YN/A
FCF growth 1Y-19.09%
FCF growth 3Y9.03%
FCF growth 5Y-6.88%
OCF growth 1Y0.65%
OCF growth 3Y4.61%
OCF growth 5Y4.02%